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Abstract
Background: The proliferating cell nuclear antigen (PCNA) is a key protein in the eukaryotic DNA replication and
cell proliferation. Following the cloning and characterisation of the human PCNA gene, the question of the
existence of pseudogenes in the human genome was raised.
Findings: In this short communication we summarise the existing information about the PCNA pseudogenes and
critically assess their status.
Conclusions: We propose the existence of at least four valid PCNA pseudogenes, PCNAP1, PCNAP2, LOC392454
and LOC390102. We would like to recommend assignment of a name for LOC392454 as “proliferating cell nuclear
antigen pseudogene 3” (alias PCNAP3) and a name for LOC390102 as “proliferating cell nuclear antigen
pseudogene 4” (alias PCNAP4). We prompt for more critical evaluation of the existence of a PCNA pseudogene,
designated as PCNAP.
Findings
The proliferating cell nuclear antigen (PCNA) is a key
protein in the eukaryotic DNA replication and cell pro-
liferation. The first observation of PCNA as an antigen
in sera, isolated from patients with systemic lupus
erythematosus, started a new field of research [1].
Already in this pioneering investigation, the function of
PCNA in cellular proliferation was revealed, however
the true nature of the antigen was not known. The iden-
tification of PCNA as an auxiliary protein to DNA poly-
merase delta [2,3], placed PCNA as a protein of a vital
importance and prompted the question of gene charac-
terisation. In the same year, the human cDNA encoding
the PCNA protein was cloned and characterised [4].
The molecular cloning of the human PCNA gene fol-
lowed soon, hinting for a possibility for existence of a
PCNA pseudogene in the genome [5]. The PCNA gene
was mapped to a locus in human chromosome 20 [6,7].
An interesting serendipity of the gene localisation was
the discovery of several related to PCNA loci, which
were proposed to contain pseudogenes of PCNA [6,7].
Since then, several reports of PCNA pseudogenes have
been published [5-9]. However, the current state and
validity of those pseudogenes is an open question. There
is considerable discrepancy between the major human-
related databases and the experimental data. In this
short communication we summarise the evidence for
the PCNA pseudogenes and try to validate their status.
There are several milestone papers describing human
PCNA pseudogenes, which for simplicity will be further
referred to as roman numerals according to their order
of publication [5-9].
The first paper (Paper I) characterises the PCNA gene,
however, it mentions a possible PCNA pseudogene [5].
The follow-up paper from the same group (Paper II)
describes this PCNA pseudogene in detail [6]. Paper I
reports that in a total genomic EcoRI digest of human
DNA, three distinct fragments can be detected by hybri-
dization with a full length cDNA probe, derived from the
human PCNA sequence. These fragments are with size
3.7 kb, 2.7 kb and 1.5 kb [5]. The larger fragments (3.7 kb
and 2.7 kb) can originate from the PCNA gene, however,
the smallest fragment (1.5 kb) was proposed to be a pro-
duct of a PCNA pseudogene [5]. Indeed, in Paper II the
existence of this the pseudogene was confirmed and its
sequence was published [6]. The sequence lacks introns
and possesses the characteristics of processed pseudo-
genes or nonviral retrotransposons [6]. This PCNA pseu-
dogene was mapped to the human chromosome X in the
region Xpter-Xq13. In Paper II, another possible locus
for a PCNA pseudogene was hypothesised to exist, situ-
ated on the human chromosome 6. The authors show
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detection of a PCNA related sequence in one of the
mouse-human somatic cell hybrid clones (N9) which
retained human chromosomes 6, 7, 21 and partial 17 [6].
The presence of a PCNA related sequence on chromo-
some 6 was investigated in another of the authors’
experiments, however, the vague and non-aligned hybri-
disation of a full length PCNA probe to chromosome 6,
presented in the paper suggests merely an artifact [6]. An
interesting conclusion from the results in the Paper II is
that if there is a PCNA pseudogene on chromosome 6, it
does not contain introns, as is the case with the PCNA
pseudogene on chromosome X. The only strong evidence
presented in the paper for existence of a PCNA pseudo-
gene on chromosome 6 is the clone N9. However, in our
opinion a careful characterization of the N9 clone is
needed in order to exclude the presence of fragments of
other human chromosomes (11, 20 and X). The argu-
ment for such characterization of the N9 clone is the
next important paper (Paper III), which maps the chro-
mosomal location of the PCNA gene and two of the
PCNA pseudogenes [7].
Indeed, in Paper III, the presence of a PCNA pseudo-
gene on chromosome 6 was not detected [7]. In Paper
III the localisation experiments for the PCNA gene and
its pseudogenes are conducted by using a probe, derived
from a fragment of the human PCNA cDNA. The
results revealed a presence of three loci, hybridising
with the probe-the PCNA gene (chromosome 20), and
two pseudogenes-on chromosome X and chromosome
11. The PCNA pseudogene on chromosome X is
mapped in the region Xp11.3-Xp11.4, which not only
confirms the location presented in Paper II, but gives a
more precise location of the proposed PCNA pseudo-
gene. The presence of a sequence which anneals with
the probe on chromosome 11 in the region 11p15.1,
represent another PCNA pseudogene.
The fourth publication (Paper IV) presents new PCNA
pseudogenes [8], which are further characterised in the
follow-up study by the same group (Paper V) [9]. Both
papers IV and V supply strong evidence for the exis-
tence of PCNA pseudogenes on chromosome 4 in the
region 4q24. The two sequences described in the paper
have already been assigned names by HUGO, “prolifer-
ating cell nuclear antigen pseudogene 1” (PCNAP1) and
“proliferating cell nuclear antigen pseudogene 2”
(PCNAP2). The existence of PCNA pseudogenes on
human chromosome 4 was proposed earlier by the same
group in Paper IV, but the later paper presents a more
detailed study and sequence of the PCNA pseudogenes.
Webb et al. failed to detect PCNA pseudogenes on the
human chromosome 4, possibly because of the limita-
tion of the probe used [8]. In fact PCNAP2 is a frag-
ment which contains sequences homologous to exon 4
and 5 of the PCNA gene [9].
In the HUGO database [10], maintained by HUGO
Gene Nomenclature Committee (HGNC), there are cur-
rently three active entries for PCNA pseudogenes:
PCNAP [11], PCNAP1 [12] and PCNAP2 [13]. The
PCNAP, PCNAP1 and PCNAP2 are present as PCNA
pseudogenes in the NCBI GENE database [14] together
with LOC392454 and LOC390102 [15].
PCNAP1 and PCNAP2 refer to the PCNA pseudogene
sequences published in Paper V.
The LOC392454 is placed in the same locus as the
PCNA pseudogene, detected by Ku et al. (Paper II) and
confirmed by Webb et al. (Paper III). We aligned the
sequence, published by Ku et al. with the sequence of
LOC392454 and found that they match very well (Figure
1). In the alignment we included two additional
sequences, which flank LOC392454 in 5’- and 3’-direc-
tion, each spanning 150 bp. The match in the flanking
sequences and the sequence of the PCNA pseudogene,
described by Ku et al., was nearly perfect with only one
mismatch (Figure 1). From the alignment, we could say
that the sequence of LOC392454 is nearly identical with
that published by Ku et al. (Figure 1). A simple pair-
wise blastn alignment gave 97% identities (752/779) and
2% gaps (15/779) [16]. Since, Ku et al. are giving experi-
mental evidence for existence of a PCNA pseudogene
on chromosome X [6], which is confirmed by Webb et
al. [7] and the sequence of this PCNA pseudogene on
chromosome X is virtually the same as the sequence of
LOC392454, we suggest that LOC392454 is a valid
PCNA pseudogene. As such, we recommend assignment
of a name for LOC392454 as “proliferating cell nuclear
antigen pseudogene 3” and the alias PCNAP3.
The LOC390102 is in the same locus as the PCNA
pseudogene, described in Paper III and mapped on
chromosome 11 (region 11p15.1). Webb et al. did not
publish a sequence of the PCNA gene located on chro-
mosome 11, however their method of detection proved
to be valid for localisation of the PCNA gene and the
PCNA pseudogene on chromosome X. Since the locali-
sation of the PCNA pseudogene, described by Webb at
al. is in the precise localisation region of LOC390102,
and there are no known PCNA pseudogenes in close
vicinity, we speculate that LOC390102 is indeed the
PCNA pseudogene, detected by Webb et al. in 1990. If
LOC390102 indeed represents a valid PCNA pseudo-
gene, we recommend assignment of a name for
LOC390102 as “proliferating cell nuclear antigen pseu-
dogene 4” and the alias PCNAP4.
The priority of PCNAP3 to PCNAP4 is given on the
basis of the first date of publication of the evidences for
existence of the respective PCNA pseudogenes.
More problematic is the designation PCNAP, given by
HUGO and mapped to the region Xp11. PCNAP is pre-
sent in the NCBI GENE database as well. Both the
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HUGO database and the NCBI GENE database refer to
the paper published by Ku et al. in 1989 [6]. There are
several discrepancies between the sequence of PCNAP
and the paper used for a reference. One is the
observation made in Paper I of a restriction fragment of
a size 1.5 kb, which hybridises with a probe based on a
full length PCNA cDNA [5]. This fragment does not
belong to the sequence of the PCNA gene and is
Figure 1 Alignment of the sequences of the PCNA pseudogene published by Ku et al. [6]and LOC392454, including 5’- and 3’-flanking
regions of LOC392454.
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proposed to represent a pseudogene [5]. Indeed, in the
follow-up paper the same group detected this pseudo-
gene, mapped it on chromosome X and presented its
sequence [6]. As we mentioned earlier this sequence
most probably represents LOC392454. We speculate
that a restriction fragment of a size 1.5 kb, which is
detected by a probe based on PCNA cDNA cannot be
produced from the sequence of PCNAP given in NCBI
GENE database (Figure 2). The aforementioned specula-
tion is based on the sequences, available from human
genome reference assembly GRC37 [17]. We used the
sequence of PCNAP and its both flanking 4 kb regions
in 3’- and 5’-direction, to predict the restriction pattern
in a total EcoRI digest (Figure 2A). The sequence of
PCNAP lies in a restriction fragment with a size of 3057
bp. A similar region of DNA, representing the
LOC392454 and its 4 kb flanking regions in 3’- and 5’-
direction, leaves LOC392454 in a hypothetical EcoRI
restriction fragment with a size of 1487 kb (Figure 2B).
The size of the predicted LOC392454 EcoRI restriction
fragment is very similar to the size observed in Paper II
and III. The other discrepancy we see is in the sequence
of PCNAP. We aligned all proposed PCNA pseudogenes
with the sequence of the PCNA gene, using mafft algo-
rithm (Figure 3) [18]. We see little or no similarity
between the sequences of the PCNAP and PCNA, as
well as between the sequences of the PCNAP and the
other PCNA pseudogenes. In contrast to PCNAP, the
sequences of all other pseudogenes (PCNAP1, PCNAP2,
LOC392454 and LOC390102) are aligning very well
with the sequence of the PCNA gene. We performed a
discontinuous megablast pair-wise alignment, using
blastn algorithm, to score how each sequence of a
proposed PCNA pseudogene aligns with the sequence of
the PCNA gene [16]. The results are presented in Table
1. The sequence of PCNAP was the only one, which
showed no significant similarity to the PCNA sequence.
The other sequences were scored as having identities
between 85% and 91% and gaps between 0% and 6% in
respect to the PCNA gene sequence (Table 1). As we
suggested above the PCNA pseudogene detected on
human chromosome X by Ku et al. is analogous to
LOC392454 and is not represented by the PCNAP
sequence. We speculate that PCNAP might not repre-
sent a valid PCNA pseudogene.
Despite of the possibility of representing valid human
PCNA pseudogenes, an interesting question is whether
the sequences of PCNAP, PCNAP1, PCNAP2,
LOC392454 and LOC390102 are present in the human
trascriptome. In order to address this question, we
checked for mRNA transcripts and expressed sequence
tagged (EST) transcripts, associated with the correspond-
ing sequences of the human PCNA pseudogenes. We
were unable to find the sequences of any of the PCNA
pseudogenes as stand-alone mRNA transcripts. However,
when we checked the transcription profile of a respective
genomic stretch in the UCSC genome browser [19], we
found that a partial sequence of PCNAP1 is present in
the A1223432, DA828011, FN062437 and CR743211
human EST transcripts. The sequence of LOC392454
was partially present in the human H79841 EST tran-
script. There are no ESTs matches with the sequences of
PCNAP, PCNAP2 or LOC390102. Despite of the exis-
tence of EST transcripts which matched the sequence of
the PCNA pseudogenes, we would like to express caution
in the interpretation of such results. ESTs libraries are
Figure 2 Predicted EcoRI restriction pattern of the two loci on human chromosome X, containing a proposed PCNA pseudogene. The
restriction endonuclease sites of AvaI are denoted for additional clarity. A) PCNAP with additional 8 kb region (4 kb flanking in 5’- and 4 kb
flanking in 3’-direction); B) LOC392454 with additional 8 kb region (4 kb flanking in 5’- and 4 kb flanking in 3’-direction). EcoRI (restriction
endonuclease I from Escherichia coli), AvaI (restriction endonuclease I from Anabaena variabilis).
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prone to non-mRNA contamination including genomic
DNA, and it is possible that the regions of interest are
not transcribed at all [20]. We also performed a BLAST
search in the human ESTs database targeting the
sequences of the proposed PCNA pseudogenes, and
although we detected matches we could not conclude
with certainty if the sequences of the PCNA pseudogenes
are transcribed or not.
Figure 3 Alignment of the sequences of the PCNA gene and the proposed PCNA pseudogenes (PCNAP1, PCNAP2, LOC392454,
LOC390102 and PCNAP).
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Conclusions
In summary we propose the existence of at least four
valid PCNA pseudogenes, PCNAP1, PCNAP2,
LOC392454 and LOC390102. We would like to recom-
mend assignment of a name for LOC392454 as “prolif-
erating cell nuclear antigen pseudogene 3” (alias
PCNAP3) and a name for LOC390102 as “proliferating
cell nuclear antigen pseudogene 4” (alias PCNAP4). We
prompt for more critical evaluation of the existence of a
PCNA pseudogene, designated as PCNAP.
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Table 1 The result from a pair-wise alignment between
the sequences of PCNA gene and the proposed PCNA
pseudogenes
Pseudogene: Identities towards PCNA Gaps towards PCNA
PCNAP1 581/718 (81%) 12/718 (2%)
PCNAP2 122/143 (85%) 8/143 (6%)
LOC392454 711/780 (91%) 3/780 (0%)
LOC390102 629/736 (85%) 4/736 (1%)
PCNAP N.S. N.S.
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